Targeted Therapies in the Fight Against Cancer

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.

Recent Webinar

Next Generation Lymphodepletion Technology for CAR-T Conditioning

Email Sign Up

Receive the latest news, events and updates!

Sign Up Now